19:53 , Dec 21, 2018 |  BC Week In Review  |  Financial News

Entrada raises $59M series A to take intracellular biologic into clinic

Entrada Therapeutics Inc. (Boston, Mass.) emerged from stealth Dec. 18 after raising $59 million in a series A round intended to propel its first intracellular biologics program into clinic. Intracellular targets have proven challenging for...
23:03 , Dec 19, 2018 |  BioCentury  |  Finance

MPM goes intracellular

MPM Capital picked Entrada Therapeutics Inc. for its debut investment in intracellular biologics because Entrada’s technology solves the long-time challenge of delivering biologics into cells and shows early promise of broad tissue distribution, MPM Capital’s...
13:00 , Dec 18, 2018 |  BC Extra  |  Financial News

Entrada raises $59M series A to take intracellular biologic into clinic

Entrada Therapeutics Inc. (Boston, Mass.) emerged from stealth Tuesday after raising $59 million in a series A round intended to propel its first intracellular biologics program into clinic. Intracellular targets have proven challenging for small...
17:25 , Aug 17, 2018 |  BC Week In Review  |  Financial News

Crossover investors join Orchard's syndicate in $150M series C

Gene therapy company Orchard Therapeutics Ltd. (London, U.K.) raised $150 million on Aug. 13 in a series C round led by Deerfield Management. Also participating were new investors RA Capital, Venrock, Foresite Capital, Perceptive Advisors,...
19:22 , Aug 13, 2018 |  BC Extra  |  Financial News

Crossover investors join Orchard's syndicate in $150M series C

Gene therapy company Orchard Therapeutics Ltd. (London, U.K.) raised $150 million in a series C round led by Deerfield Management. Also participating were new investors RA Capital, Venrock, Foresite Capital, Perceptive Advisors, Cormorant Asset Management,...
17:26 , Jul 20, 2018 |  BC Week In Review  |  Financial News

DFJ leads Verge Genmics' $32M series A round

Neuroscience company Verge Genomics Inc. (San Francisco, Calif.) raised $32 million in a series A round led by DFJ on July 16. New investors included the corporate venture fund of WuXi AppTec Co. Ltd. (Shanghai:603259),...
16:35 , Jul 20, 2018 |  BC Week In Review  |  Financial News

Fibrotic disease company Pliant raises $62M series B

Fibrosis play Pliant Therapeutics Inc. (Redwood City, Calif.) raised $62 million on July 16 in an untranched series B round led by Cowen Healthcare Investments. Fellow new investors Eventide Asset Management, Schroder Adveq, Menlo Ventures,...
17:45 , Jul 18, 2018 |  BioCentury  |  Finance

Fibrosis firsts

Pliant Therapeutics Inc.’s preclinical models and discovery technology prompted Cowen Healthcare Investments and Menlo Ventures to choose the company as their first fibrosis investments. Cowen led Pliant’s untranched $62 million series B round on Monday,...
16:45 , Jul 16, 2018 |  BC Extra  |  Financial News

Fibrotic disease company Pliant raises $62M series B

Fibrosis play Pliant Therapeutics Inc. (Redwood City, Calif.) raised $62 million in an untranched series B round led by Cowen Healthcare Investments. Fellow new investors Eventide Asset Management, Schroder Adveq, Menlo Ventures, SCubed Capital, Agent...
11:01 , Jul 16, 2018 |  BC Extra  |  Financial News

DFJ leads Verge Genomics' $32M series A round

Neuroscience company Verge Genomics Inc. (San Francisco, Calif.) raised $32 million in a series A round led by DFJ. New investors included the corporate venture fund of WuXi AppTec Co. Ltd. (Shanghai:603259), ALS Investment Fund,...